← Eichor
Study identifier: NCT06022549 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effects of mHealth Message on Metabolic Syndrome and Bone Loss of HIV Infected Persons in Taiwan

Condition: Hiv  ·  Sponsor: National Taiwan University

PhaseN/A
Planned participants400
Who can joinAll sexes, 30 Years to no upper limit
Healthy volunteersNo

About this study

With improved AIDS treatment leading to extended survival, HIV-infected individuals face a higher metabolic syndrome incidence. This study aims to determine the prevalence of Non-AIDS related Comorbidities (NARC) in HIV-infected individuals. Using purposive and snowball sampling, the cross-sectional survey targets 400 HIV-infected individuals aged 30 and above. Data collection includes demographics, physical activity, nutrition, depression, and physiological measurements. Analyzing the data through statistical tests and structural equation modeling, the study aims to provide precise care recommendations for preventive medicine and healthy aging in this population.

This description comes directly from the study's public registry record.

Talk to the study team

PIAO-YI CHIOU, doctoral  ·  +886-2-23123456  ·  piaoyi@ntu.edu.tw

Always discuss trial participation with your own doctor first.

Locations (1)

National Taiwan University, College of Medicine, School of NursingTaipei, TaiwanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06022549